Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

I agree. She stumbled a bit at the opening but hit her stride soon enough. I thought she was really good at presenting the financial side of the picture (as one might assume). She demonstrated a pretty compelling story about the income streams and a highlight was her clear emphasis on the strength of the Enhanze side, going so far to say that there were a potential for about 150 more targets and that the deals were coming with more frequency. She might be able to have raised some eyebrows among a previously disinterested number of folks in the room. Well done, I'd say.
Good luck!
-Fritz